Boylan et al., 1973 - Google Patents
Molecular-scale drug entrapment as a precise method of controlled drug release IV: Entrapment of anionic drugs by polymeric gelationBoylan et al., 1973
- Document ID
- 12786122970526800980
- Author
- Boylan J
- Banker G
- Publication year
- Publication venue
- Journal of Pharmaceutical Sciences
External Links
Snippet
A physicochemical approach to the preparation of drug-containing matrix systems is described in which a soluble anionic drug may be entrapped on a molecular scale in coagulated (gelled) polymer emulsion systems. The resultant dried product (or drug-xerogel …
- 239000003814 drug 0 title abstract description 111
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3629392A (en) | Entrapment compositions and processes | |
AU565354B2 (en) | Bioadhesive compositions and methods of treatment therewith | |
US3608063A (en) | Molecular drug entrapment process and compositions | |
US4795436A (en) | Bioadhesive composition and method of treatment therewith | |
US3499960A (en) | Palatable coated particles of an anion exchange resin | |
HOU et al. | Sustained release of indomethacin from chitosan granules | |
JP2662253B2 (en) | Polymer blends with reversed-phase morphology for controlled release of bioactive agents | |
US4221778A (en) | Prolonged release pharmaceutical preparations | |
US5183829A (en) | Oral liquid compositions of non-steroidal anti-inflammatory drugs | |
Motycka et al. | Preparation and evaluation of microencapsulated ion-exchange resin beads | |
Bloedow et al. | Effects of lipids on bioavailability of sulfisoxazole acetyl, dicumarol, and griseofulvin in rats | |
Sheth et al. | Use of powdered solutions to improve the dissolution rate of polythiazide tablets | |
Boylan et al. | Molecular-scale drug entrapment as a precise method of controlled drug release IV: Entrapment of anionic drugs by polymeric gelation | |
Goodman et al. | Molecular-scale drug entrapment as a precise method of controlled drug release I: Entrapment of cationic drugs by Polymeric flocculation | |
US5087455A (en) | Hollow granular medicine and its preparation | |
Boggiano et al. | Gastric acid inactivation of erythromycin stearate in solid dosage forms | |
CN110146500B (en) | Method for determining free bismuth in colloidal bismuth pectin or colloidal bismuth pectin-containing preparation | |
AU663695B2 (en) | Polyamine drug-resin complexes | |
Bondesen et al. | 5-Aminosalicylic acid enemas in patients with active ulcerative colitis: influence of acidity on the kinetic pattern | |
USRE28316E (en) | Entrapment compositions and processes | |
DE69319064T2 (en) | Biologically active reagent made from polymer containing aldehyde groups, test equipment, analytical element and application methods | |
Pongpaibul et al. | Effect of process variables on drug release from microparticles containing a drug-resin complex | |
Szejtli | Enhancement of drug bioavailability by cyclodextrins | |
Jambhekar et al. | pH‐and flow‐rate‐independent release of drug from uncoated slow‐release tablets | |
Capan et al. | Formulation and in vitro-in vivo evaluations on sustained release acetylsalicylic acid tablets |